Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EU & NICE authorise MSD's Keytruda for stage III melanoma

pharmatimesDecember 20, 2018

Tag: msd , NICE , EU

PharmaSources Customer Service